Literature DB >> 21801506

Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load.

J Ghosh1, C S Lal, K Pandey, V N R Das, P Das, K Roychoudhury, S Roy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21801506      PMCID： PMC4090785          DOI： 10.1179/136485911X12899838683566

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  20 in total

1.  Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Authors:  Subha Banerjee; June Ghosh; Subha Sen; Rajan Guha; Ranjan Dhar; Moumita Ghosh; Sanchita Datta; Bikramjit Raychaudhury; Kshudiram Naskar; Arun Kumar Haldar; C S Lal; K Pandey; V N R Das; Pradeep Das; Syamal Roy
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

2.  Lactate dehydrogenase and other enzymes in kala-azar patients in Iraq.

Authors:  N R Al-Saffar; S A Al-Mudhaffer
Journal:  Indian J Med Res       Date:  1979-10       Impact factor: 2.375

3.  Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation.

Authors:  H A Anderson; E M Hiltbold; P A Roche
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

4.  Kinetic enzymic method for automated determination of total cholesterol in serum.

Authors:  R Deeg; J Ziegenhorn
Journal:  Clin Chem       Date:  1983-10       Impact factor: 8.327

5.  Report of the Conference on Low Blood Cholesterol: Mortality Associations.

Authors:  D Jacobs; H Blackburn; M Higgins; D Reed; H Iso; G McMillan; J Neaton; J Nelson; J Potter; B Rifkind
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

6.  Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis.

Authors:  J D Chulay; A D Bryceson
Journal:  Am J Trop Med Hyg       Date:  1983-05       Impact factor: 2.345

7.  Epidemiology of visceral leishmaniasis in northeast Brazil.

Authors:  T G Evans; M J Teixeira; I T McAuliffe; I Vasconcelos; A W Vasconcelos; A de A Sousa; J W Lima; R D Pearson
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

8.  Enhancement of the antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosis.

Authors:  D A Hughes; P J Townsend; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

9.  Dyslipoproteinemia in patients with severe bacterial infections.

Authors:  B Akerlund; L A Carlson; C Jarstrand
Journal:  Scand J Infect Dis       Date:  1986

Review 10.  The immunobiology of leishmaniasis.

Authors:  R D Pearson; D A Wheeler; L H Harrison; H D Kay
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct
View more
  17 in total

1.  Lipids: a key player in the battle between the host and microorganisms.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2012-10-17       Impact factor: 5.922

Review 2.  The role of extracellular vesicles in Plasmodium and other protozoan parasites.

Authors:  Pierre-Yves Mantel; Matthias Marti
Journal:  Cell Microbiol       Date:  2014-03       Impact factor: 3.715

Review 3.  Tryp-ing Up Metabolism: Role of Metabolic Adaptations in Kinetoplastid Disease Pathogenesis.

Authors:  Adwaita R Parab; Laura-Isobel McCall
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

4.  Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasis.

Authors:  C S Lal; R B Verma; N Verma; N A Siddiqui; V N Rabidas; K Pandey; D Singh; S Kumar; R K Paswan; A Kumari; P Sinha; P Das
Journal:  Infection       Date:  2015-07-10       Impact factor: 3.553

5.  Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.

Authors:  June Ghosh; Shantanabha Das; Rajan Guha; Debopam Ghosh; Kshudiram Naskar; Anjan Das; Syamal Roy
Journal:  J Lipid Res       Date:  2012-10-10       Impact factor: 5.922

6.  Liposomal cholesterol delivery activates the macrophage innate immune arm to facilitate intracellular Leishmania donovani killing.

Authors:  June Ghosh; Rajan Guha; Shantanabha Das; Syamal Roy
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

7.  Cholesterol lowering drug may influence cellular immune response by altering MHC II function.

Authors:  Koushik Roy; Moumita Ghosh; Tuhin Kumar Pal; Saikat Chakrabarti; Syamal Roy
Journal:  J Lipid Res       Date:  2013-09-13       Impact factor: 5.922

8.  Restoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani infected macrophages: role of membrane cholesterol.

Authors:  Subha Sen; Koushik Roy; Sandip Mukherjee; Rupkatha Mukhopadhyay; Syamal Roy
Journal:  PLoS Pathog       Date:  2011-09-08       Impact factor: 6.823

9.  Leishmania donovani infection enhances lateral mobility of macrophage membrane protein which is reversed by liposomal cholesterol.

Authors:  Moumita Ghosh; Koushik Roy; Dipanwita Das Mukherjee; Gopal Chakrabarti; Kingshuk Roy Choudhury; Syamal Roy
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

10.  Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection.

Authors:  June Ghosh; Mainak Bose; Syamal Roy; Suvendra N Bhattacharyya
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.